期刊文献+

青蒿琥酯抑制人肝癌细胞株HepG2细胞生长及其机制的初步研究 被引量:1

Primary research on artesunate inhibiting human hepatoma cell lines HepG2 cells growth and its mechanisms
原文传递
导出
摘要 目的:研究青蒿琥酯对人肝癌细胞株HepG2细胞增殖和survivin表达的影响,探讨青蒿琥酯影响肝癌细胞增殖的可能机制.方法:常规培养人肝癌细胞株HepG2,设立空白对照组;青蒿琥酯不同浓度组(3.125μg/ml、6.25μg/ml、12.5μg/ml、50μg/ml),作用不同时间后用MTT法检测青蒿琥酯对人肝癌细胞株HepG2细胞增殖的影响,应用RT-PCR检测细胞survivin在mRNA水平的表达.结果:青蒿琥酯作用人肝癌细胞株HepG2后,与对照组比较细胞生长明显受到抑制(P〈0.05),当青蒿琥酯浓度在12.5μg/ml时,survivin的表达(相对表达量为(0.75+0.01)显著降低(P〈0.05).结论:青蒿琥酯可通过下调survivin的表达来抑制肝癌细胞HepG2的生长. Objective:Its aimed to investigate the effects of artesunate on proliferation and surviving expressions of human hepatoma cell lines HepG2,human hepatoma cell lines HepG2 cultivated by convention, were randomly divided into 2 groups:untreated control group; different concentration artesunate treated with HepG2. And then, the proliferation of HepG2 were detected by MTT; After treated with different concentration for 48 hours,using RT-PCR method to detect survivin expression at the mRNA level. Results:Compared with the control group, the proliferation of HepG2 was significantly inhibited by artesunate(P 〈 0.05) ;when the concentration of artesunate reach to 12.5μg/ml, the survivin expressionin(relative expression levels of 0. 75±0. 01) were significantly lower(P 〈 0.05). Conclusion: Artesunate can inhibited the proliferation of H epG2 through reducing the expressionin of the surviving.
出处 《按摩与康复医学》 2010年第21期1-2,共2页 Chinese Manipulation and Rehabilitation Medicine
关键词 青蒿琥酯 肝癌细胞株HEPG2 SURVIVIN Artesunate Human henatoma cell lines HenG2 Survivin
  • 相关文献

参考文献9

  • 1Posner GH,Paris IH,SUR s,et al.Orally active,antimalarial,anticancer,artemisin-derived trioxane dimmers with high stability and efficacy.J Med Chen,2003,46:1060-5.
  • 2Efferth T,Dustan H,Sauerbrey A,Miyachi H,Chitambar CR.The antimalarial artesunate in tumor cell lines.Mol Pharmacol,2003,64:382-94.
  • 3Li Y,Shan F,Wu JM,et al.Renard P Novel antitumor artemisinin derivatives targeting G1 phase of the cell cycle[J].Bioorg Med Chem Lett,2001,11(1):528.
  • 4Woerdenbag HJ,Moskal TA,Pras N,er al.Cytotoxicity of artemisin-related endoperoxides to Ehrlich ascites tumor cells.J Nat Prod,1993,56:849-56.
  • 5Adida C,Crotty PL,McGrath J,etal.Developmentally regulated expression of the novel cancer anti-apoptosis gene survivin in human and mouse differentiation[J].AmJ Pathol,1998,152(1):43-49.
  • 6Ambr osiniG,AdidaC,SirugoG,et al.Induction of apop tosis and inhibiti on of cell p roliferati on by survivin gene targeting[J].Jbiol Chem,1998,273(5):11177-11182.
  • 7ShinS,Sung BJ,hoYS,et al.An anti-apoptotic protein human Survivin is a direct inhibitor of caspase-3 and caspase-7[J].Biochemistry,2001,40(4):1117-1123.
  • 8王滋宗,魏煜程,沈毅,杨景伟.非小细胞肺癌组织Survivin和Caspase基因表达及其关系[J].青岛大学医学院学报,2008,44(4):319-321. 被引量:11
  • 9Verdecia MA,HuanH,DutilE,et al.Structure of the human antiapototic protein survivin reveals a dimeric arrangement[J].NatStruct Biol,2000,7(7):602-608.

二级参考文献13

  • 1汪道峰,曾灿光,林勇斌,侯景辉,朱志华.凋亡相关基因在Ⅰ、Ⅱ期非小细胞肺癌组织中的表达及临床意义[J].癌症,2006,25(3):359-362. 被引量:7
  • 2刘红菊,陶晓南,白明,周琼,张小菊,尚丹.凋亡抑制基因survivin bcl-2 bax在肺癌中表达的研究[J].中国实用内科杂志,2007,27(10):767-769. 被引量:5
  • 3杨景伟,魏煜程,沈毅,马若云.Fas和Ki-67在非小细胞肺癌组织中的表达[J].齐鲁医学杂志,2007,22(3):212-214. 被引量:4
  • 4AMBROSINI G, ADIDA C, ALTIERI D C. A novel antiapoptosis gene, survivin, expressed in cancer and lymphoma [J]. Nat Med, 1997,3(8) :917-921.
  • 5LU C D, ALTIERI D C, TANIGAWA N. Expression of a novel antlapoptosis gene, surviving, correlated with tumor cell apoptosis and p53 accumulation in gastric carcinomas [J]. CancerRes, 1998,58(9): 1808-1812.
  • 6LEHNER R, ENOMOTO T, MCGREGOR J A, et al. Correlation of surviving mRNA detection with histologic diagnosis in nomal endometrium and endometrial carcinoma[J]. Acta Obstet Gynecol Stand, 2002,819(2) : 162- 167.
  • 7CALDAS H, HONSEY L E, ALTURE R A, et al. Survivin 2 alpha:a novel Survivin splice variant expressed in human malignancies[J]. MolCancer, 2005,4:11.
  • 8MAHOTKA C, WENZEL M, SPRINGER E, et al. SurvivindeltaEx3 and survivin-2B: two novel splice variants of the apoptosis inhibitor survivin with differentant antiapoptotic properties[J]. CancerRes, 1999,59(24):6097- 6102.
  • 9SARELA A I, MACADAM R C, FARMERY S M, et al. Ex pression of the antiapoptosis gene, surviving, predicts death from recurrent colorectal carcinoma[J]. Gut, 2000, 46 (5): 645 -650.
  • 10BANKS D P, PLESCIA J, ALTIEIR D C, et al. Survivin does not inhibit caspase 3 activity[J]. Blood, 2000,96 (12): 4002-4003.

共引文献10

同被引文献9

  • 1迟丹怡,王大猷,李虹影,李中东,时颖华,王宏图,钟明康.心血管病房药物不良事件的危险因素研究[J].中国药学杂志,2005,40(21):1672-1674. 被引量:5
  • 2Mc Cracken M,Olsen M,Chen MS Jr,et al.Cancer incidence,mortality,and associated risk factors among Asian Americans of Chinese,Filipino,Vietnamese,Korean,and Japanese ethnicities[J].CA Cancer J Clin,2007,57:190-205.
  • 3Posner GH,Northrop J,Paik IH,et al.New chemical and biological aspects of artemisinin-derived trioxane dimmers[J].Bioorg Med Chem,2002,10:227-232.
  • 4Galal AM,Ross SA,ElSohly MA,et al.Deoxyartemisinin derivatives from photooxygenation of anhydrodeox dihydroartemisinin and their cytotoxic evaluation[J].J Nat Prod,2002,65:184-188.
  • 5Michaelis M,Kleinschmidt MC,Barth S,et al.Anti-cancer effects of artesunate in a panel of chemoresistant neuroblastoma cell lines[J].Biochem Pharmacol,2010,79:130-136.
  • 6Efferth T,Dunstan H,Sauerbrey A,et al.The anti-malarial artesunate is also active against cancer[J].Int J Oncol,2001,18:767-773.
  • 7Badvie S.Hepatocellular Carcinoma[J].Postgrad Med J,2000,76:4-11.
  • 8Chen PQ,Yuan J,Du QY,et al.Effects of dihydroartemisinin on fine structure of srythrocytic stages of plaslmodium berghei ANKA strain[J].Acta Pharmacol Sin,2000,21(3):234.
  • 9孙玮辰,韩家娴.四种青蒿酸及青蒿B衍生物的体外抗癌作用[J].中国药理学报,1992,13(6):541-543. 被引量:39

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部